BMCM
PFE icon

Bryn Mawr Capital Management’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.87M Buy
76,960
+8,075
+12% +$196K 0.1% 152
2025
Q1
$1.75M Sell
68,885
-3,248
-5% -$82.3K 0.1% 149
2024
Q4
$1.91M Sell
72,133
-12,317
-15% -$327K 0.1% 156
2024
Q3
$2.44M Sell
84,450
-109,585
-56% -$3.17M 0.13% 138
2024
Q2
$5.43M Sell
194,035
-6,206
-3% -$174K 0.3% 76
2024
Q1
$5.56M Buy
200,241
+25,825
+15% +$717K 0.32% 79
2023
Q4
$5.02M Sell
174,416
-69,173
-28% -$1.99M 0.31% 81
2023
Q3
$8.08M Buy
243,589
+23,457
+11% +$778K 0.53% 46
2023
Q2
$8.07M Buy
220,132
+12,114
+6% +$444K 0.76% 35
2023
Q1
$8.49M Sell
208,018
-7,803
-4% -$318K 0.88% 31
2022
Q4
$11.1M Buy
215,821
+203,656
+1,674% +$10.4M 1.19% 23
2022
Q3
$532K Sell
12,165
-70
-0.6% -$3.06K 0.19% 87
2022
Q2
$641K Sell
12,235
-400
-3% -$21K 0.21% 87
2022
Q1
$654K Buy
12,635
+550
+5% +$28.5K 0.18% 92
2021
Q4
$714K Sell
12,085
-130
-1% -$7.68K 0.27% 47
2021
Q3
$525K Buy
12,215
+2,080
+21% +$89.4K 0.24% 54
2021
Q2
$397K Hold
10,135
0.18% 64
2021
Q1
$367K Buy
10,135
+49
+0.5% +$1.77K 0.18% 63
2020
Q4
$371K Sell
10,086
-600
-6% -$22.1K 0.18% 61
2020
Q3
$392K Buy
10,686
+1,967
+23% +$72.2K 0.23% 56
2020
Q2
$285K Sell
8,719
-3,665
-30% -$120K 0.18% 67
2020
Q1
$404K Sell
12,384
-67
-0.5% -$2.19K 0.27% 47
2019
Q4
$488K Buy
12,451
+164
+1% +$6.43K 0.35% 45
2019
Q3
$441K Sell
12,287
-1,385
-10% -$49.7K 0.37% 45
2019
Q2
$592K Buy
13,672
+2,484
+22% +$108K 0.5% 37
2019
Q1
$475K Sell
11,188
-715
-6% -$30.4K 0.43% 40
2018
Q4
$520K Sell
11,903
-59
-0.5% -$2.58K 0.47% 37
2018
Q3
$527K Sell
11,962
-600
-5% -$26.4K 0.44% 36
2018
Q2
$456K Buy
12,562
+179
+1% +$6.5K 0.4% 41
2018
Q1
$439K Buy
+12,383
New +$439K 0.4% 38
2017
Q4
Sell
-12,213
Closed -$436K 71
2017
Q3
$436K Buy
+12,213
New +$436K 0.45% 36
2017
Q2
Sell
-12,908
Closed -$442K 83
2017
Q1
$442K Buy
12,908
+279
+2% +$9.55K 0.45% 40
2016
Q4
$410K Buy
+12,629
New +$410K 0.42% 42